Delivery Order SPE2DB20D3101-SPE2DB25FRWB1
- Not listed
- This is a $1,322.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qnasl 80 mcg nasal spray (10.6 grams) with a ceiling value of $4,980.26. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Qnasl 80 mcg nasal spray (10.6 grams) with a contract ceiling value of $2,486.72 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 2, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with...
- This delivery order, awarded September 5, 2025, provides QNASL 80 MCG nasal spray (10.6 GM) to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract represents a firm fixed-price delivery order with a ceiling value of $4,189.84 and an ultimate completion date of September 8, 2025. The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.30 to AmerisourceBergen Drug Corp for Qnasal 80 mcg nasal spray (10.6 grams) on September 10, 2025, with an ultimate completion date of September 11, 2025. This contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a $526,290 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for 4561569109 QNASL 80 MCG nasal spray. The prime contractor will provide 10.6 grams of the nasal spray medication to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on July 24, 2023. No major subcontractors or set-aside designations were identified. The Defense...
- This $1,717.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on June 12, 2024. The order is for the supply of 4564885519 QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- The Defense Logistics Agency awarded a $539 delivery order to Amerisourcebergen Drug Corporation for 4561491125 QNASL 80 microgram nasal spray. The firm fixed price order is for 10.6 grams of the nasal spray medication to support DLA programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 13 to July 14, 2023. No major subcontractors or set aside designations were identified. This order is a small transaction under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,349.47, is a delivery order for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a specialty medication. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $774 delivery order to Amerisourcebergen Drug Corporation for 4561964200 QNASL 80 MCG nasal spray. As part of DLA's medical supply chain responsibilities, this firm fixed price order is for approximately 10.6 grams of the nasal spray medication to support DLA customers. Amerisourcebergen will deliver the product from its Conshohocken, Pennsylvania distribution facility by the end of August 2023 under the terms of the order. No set aside provisions or...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWB1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,542.48 to AmerisourceBergen Drug Corp for QNASL 80 MCG Nasal Spray (10.6 GM) with a completion deadline of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support Medical is planning subsequent Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a critical vendor within the federal medical procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/22/25 |